US Bancorp DE Increases Position in The Clorox Company (NYSE:CLX)

US Bancorp DE raised its position in The Clorox Company (NYSE:CLX) by 0.4% during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 134,416 shares of the company’s stock after purchasing an additional 531 shares during the period. US Bancorp DE’s holdings in Clorox were worth $21,378,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors also recently modified their holdings of CLX. Bogart Wealth LLC increased its position in shares of Clorox by 105.6% in the 2nd quarter. Bogart Wealth LLC now owns 185 shares of the company’s stock valued at $29,000 after purchasing an additional 95 shares during the last quarter. Ten Capital Wealth Advisors LLC grew its position in shares of Clorox by 429.7% in the 1st quarter. Ten Capital Wealth Advisors LLC now owns 196 shares of the company’s stock valued at $31,000 after buying an additional 159 shares during the last quarter. Strategic Investment Solutions Inc. IL purchased a new position in shares of Clorox in the 1st quarter valued at $31,000. Barrett & Company Inc. grew its position in shares of Clorox by 540.5% in the 2nd quarter. Barrett & Company Inc. now owns 237 shares of the company’s stock valued at $38,000 after buying an additional 200 shares during the last quarter. Finally, Compass Wealth Management LLC purchased a new position in shares of Clorox in the 4th quarter valued at $39,000. 77.98% of the stock is owned by hedge funds and other institutional investors.

Clorox Stock Up 0.1 %

CLX stock opened at $139.17 on Friday. The Clorox Company has a one year low of $114.68 and a one year high of $178.21. The stock has a market capitalization of $17.26 billion, a PE ratio of 204.65, a price-to-earnings-growth ratio of 3.02 and a beta of 0.35. The company has a debt-to-equity ratio of 18.92, a quick ratio of 0.54 and a current ratio of 0.86. The company has a fifty day moving average of $130.12 and a 200-day moving average of $148.67.

Clorox (NYSE:CLX) last released its earnings results on Wednesday, November 1st. The company reported $0.49 EPS for the quarter, topping the consensus estimate of ($0.20) by $0.69. Clorox had a net margin of 1.22% and a return on equity of 195.76%. The company had revenue of $1.39 billion during the quarter, compared to analysts’ expectations of $1.31 billion. During the same quarter last year, the business earned $0.93 EPS. The business’s revenue was down 20.3% on a year-over-year basis. As a group, analysts expect that The Clorox Company will post 4.51 EPS for the current year.

Clorox Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 9th. Investors of record on Wednesday, January 24th will be paid a $1.20 dividend. This represents a $4.80 annualized dividend and a dividend yield of 3.45%. The ex-dividend date is Tuesday, January 23rd. Clorox’s dividend payout ratio (DPR) is 705.88%.

Wall Street Analysts Forecast Growth

A number of research analysts recently commented on the stock. Barclays dropped their target price on shares of Clorox from $127.00 to $116.00 in a research report on Thursday, October 5th. Wells Fargo & Company dropped their target price on shares of Clorox from $140.00 to $135.00 in a research report on Thursday, October 5th. Bank of America dropped their target price on shares of Clorox from $145.00 to $120.00 and set an “underperform” rating on the stock in a research report on Thursday, October 5th. Sanford C. Bernstein upgraded shares of Clorox from an “underperform” rating to a “market perform” rating and set a $120.00 price target for the company in a research note on Thursday, October 12th. Finally, HSBC initiated coverage on shares of Clorox in a research note on Friday, September 22nd. They set a “hold” rating and a $146.00 price target for the company. Six equities research analysts have rated the stock with a sell rating, eight have given a hold rating and two have issued a buy rating to the stock. According to MarketBeat.com, Clorox currently has a consensus rating of “Hold” and a consensus target price of $138.13.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.